Cardiovascular Pharmacogenetics

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Cardiovascular Pharmacogenetics by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783662062142
Publisher: Springer Berlin Heidelberg Publication: April 17, 2013
Imprint: Springer Language: English
Author:
ISBN: 9783662062142
Publisher: Springer Berlin Heidelberg
Publication: April 17, 2013
Imprint: Springer
Language: English

The Human Genome Project was sold to the general public largely on the basis that a complete picture of the structure of human DNA would lead to new and better medicines. These medicines would be better because they would be tailored to individual patients, maximising the chances of a therapeutic response and mi­ nimising the risks of an adverse event. Taking the idea further, pundits have pre­ dicted that the time will come when we could carry our DNA on a card which could be read rapidly and enable the physician to choose the best drug. This is the future. This is pharmacogenetics. When the draft human DNA sequence was announced and scientists were as­ ked how this would help drug development, the example most frequently given was the debrisoquine model - where poor metabolisers of this hypotensive agent are exposed to higher plasma levels from a standard dose and at risk of collapse from excessive hypotension. This observation was made over 20 years ago and predated designs to sequence the human genome. Nonetheless, it raised aware­ ness of variation in drug metabolism and was correctly assigned to genetic poly­ morphisms affecting CYP2D6. Together with the discovery of pseudocholinestera­ se deficiency, it marked the birth of pharmacogenetics. The debrisoquine example is an interesting one and worthy of further analysis.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The Human Genome Project was sold to the general public largely on the basis that a complete picture of the structure of human DNA would lead to new and better medicines. These medicines would be better because they would be tailored to individual patients, maximising the chances of a therapeutic response and mi­ nimising the risks of an adverse event. Taking the idea further, pundits have pre­ dicted that the time will come when we could carry our DNA on a card which could be read rapidly and enable the physician to choose the best drug. This is the future. This is pharmacogenetics. When the draft human DNA sequence was announced and scientists were as­ ked how this would help drug development, the example most frequently given was the debrisoquine model - where poor metabolisers of this hypotensive agent are exposed to higher plasma levels from a standard dose and at risk of collapse from excessive hypotension. This observation was made over 20 years ago and predated designs to sequence the human genome. Nonetheless, it raised aware­ ness of variation in drug metabolism and was correctly assigned to genetic poly­ morphisms affecting CYP2D6. Together with the discovery of pseudocholinestera­ se deficiency, it marked the birth of pharmacogenetics. The debrisoquine example is an interesting one and worthy of further analysis.

More books from Springer Berlin Heidelberg

Cover of the book The Permian of Northern Pangea by
Cover of the book Southern Hemisphere Paleo- and Neoclimates by
Cover of the book Natural Gas Hydrates by
Cover of the book The Narrow Lumbar Canal by
Cover of the book Singular Spectrum Analysis for Time Series by
Cover of the book The Blood Brain Barrier (BBB) by
Cover of the book Maschinendynamik by
Cover of the book A Short Journey from Quarks to the Universe by
Cover of the book Values of Our Times by
Cover of the book Scattering from Model Nonspherical Particles by
Cover of the book Geology and Resource Potential of the Congo Basin by
Cover of the book New Concepts in Maxillofacial Bone Surgery by
Cover of the book Organismische Rekorde by
Cover of the book Sustainable C(sp3)-H Bond Functionalization by
Cover of the book Workplace Learning by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy